Prevalence of methicillin-sensitive and methicillin-resistant staphylococci in intensive care units in a University hospital

European Journal of General Medicine

Volumn 2, Issue 1, 2005, Pages 20-26

  Savaş, Lütfü ^a   Duran, Nizami ^a,c   Önlen, Yusuf ^a   Savaş, Nazan ^a   Ocak, Sabahattin ^a   Iris, Nur Efe ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c Gullu Bahce Mahallesi   (Turkey)

Author keywords

ICUs; Methicillin; MRSA; Staphylococci; Susceptibility

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; NORFLOXACIN; OFLOXACIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD SAMPLING; BURN; CONTROLLED STUDY; HEALTH CARE; HOSPITAL; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT CARE; STAPHYLOCOCCUS INFECTION; URINALYSIS;

EID: 33846705864     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82261     Document Type: Article

References (21)

1. Archibald L, Phillips L, Monnett D, et al. Antimicrobial resistance in hospitals and outpatients in the United States: the increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-5
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520
3. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1996;11:479-96
4. Ayliffe GAJ. The progressive intercontinental spread of methicillin resistant Staphylococcus aureus. Clin Infect Dis 1997;24(Suppl. 1):S74-S79
5. Boyce JM. Are the epidemiology and microbiology of methicillin resistant Staphylococcus aureus changing. JAMA 1998;279:623-4
6. Garrouste-Orgeas M, Timsit JF, Kallel H et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients morbidity, mortality and glycopeptide use. Infect_Control Hosp Epidemiol 2001;22:687
7. Hunt JL, Purdue GF, Tuggle DW. Morbidity and mortality of an endemic pathogen: methicillin resistant Staphylococcus aureus. Am J Surg 1988;156:524-7
8. Cookson BD. Nosocomial antimicrobial resistance surveillance. J Hosp Infect 1999;(Suppl. 1):97-103
9. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe-results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274(8):639-44
10. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology 7 Edition Washington, DC: American Society for Clinical Microbiology, 1999
11. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Tests for Bacteria that grow Aerobically; Approved Standard 5 Edition Villanova, PA: NCCLS, 2000
12. Vincent JL. Nosocomial infections in adult intensive-care units. Lancet 2003;361:2068-77
13. Telecco S, Barbarini D, Carretto E et al. Typing of methicillin-resistant Staphylococcus aureus (MRSA) strains from an intensive care unit by random amplified polymorphic DNA (RAPD). New Microbiol 1999;22(4):323-9
14. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999;115(3):34S-41S
15. Hiramatsu K, Hanaki H, Ino T et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-6
16. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999;340: 517-23
17. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep 1997;46:813-5
18. Cercenado E, Garcia-Leoni ME, Diaz MD, et al. Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996;34:1765-8
19. Del'Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagn Microbiol Infect Dis 1999;34:185-91
20. Sieradzki K, Villari P, Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother 1998;42:100-7
21. Jarvis WR. Preventing the emergence of multidrugresistant microorganisms through antimicrobial use controls: The complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490-5